It is not known if it was a coincidence, but the truth is that Nacho Figueras launched a new jam of Meghan Markle hours before Kate Middleton made her first public appearance after almost six months of absence due to her cancer treatment.
PUBLICIDAD
On Friday night, the argentinean Nacho Figueras posted a photo on their Instagram story of a jar of raspberry jam from the American Riviera Orchard brand, owned by the Duchess of Sussex.
PUBLICIDAD
Nacho Figueras is a close pal of Meghan Markle and Prince Harry. In another Instagram story, he announced that she will also be launching dog biscuits packaged in a glass jar with a design very similar to that of jam, complete with a ribbon and packaging in cursive lettering.
Hours before the publication of Meghan Markle’s jam, Princess Kate Middleton announced that she would be present this Saturday at the Trooping the Colour, and indeed she was. Although the event was in honor of King Charles III’s birthday, the Princess of Wales stole all the attention, as everyone was eager to see her publicly for the first time this year. The last time she was seen at a public event was during the Christmas festivities of 2023.
Meghan Markle and the "jam war"
Meghan Markle launched her jam brand in April of this year, and days later, on the 24th of that month, Buckingham Palace posted a video on their Instagram account for the Buckingham Palace Shop, promoting their strawberry jam, which many questioned if it was a coincidence.
"Our strawberry reserve is made using only the best berries and is delicious served in various ways," wrote Buckingham Palace Shop alongside the video.
Some Instagram users described the event as "the jam war."
Meanwhile, it is being reported that Meghan Markle and Prince Harry are looking for a house in the United Kingdom, supposedly to constantly travel between this region and the United States. However, it is said that the one who likes this idea the least is Queen Camilla, whom the youngest son of King Charles III described as “wicked” in his memoirs and blamed for allegedly leaking information to the press.